We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+8.09%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$224M
AUM Growth
-$13.2M
Cap. Flow
-$18.5M
Cap. Flow %
-8.26%
Top 10 Hldgs %
19.28%
Holding
249
New
32
Increased
56
Reduced
130
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 11.59%
2 Financials 8.75%
3 Communication Services 7.99%
4 Healthcare 7.43%
5 Consumer Discretionary 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
201
Freeport-McMoran
FCX
$90B
$221K 0.1%
+11,391
New +$164K
SCZ icon
202
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$219K 0.1%
+3,528
New +$202K
VUG icon
203
Vanguard Morningstar Growth ETF
VUG
$220B
$214K 0.1%
+5,586
New +$206K
MTUM icon
204
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
$212K 0.09%
+1,437
New +$205K
IPKW icon
205
Invesco International BuyBack Achievers ETF
IPKW
$551M
$211K 0.09%
6,738
-1,780
-21% -$55.9K
CAT icon
206
Caterpillar
CAT
$375B
$206K 0.09%
+1,326
New +$186K
ARCC icon
207
Ares Capital
ARCC
$13.5B
$153K 0.07%
10,710
-1,039
-9% -$14.8K
CLVS
208
DELISTED
Clovis Oncology, Inc.
CLVS
$141K 0.06%
24,250
+200
+0.8% +$1.2K
PRTK
209
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$136K 0.06%
24,550
-500
-2% -$2.48K
GE icon
210
GE Aerospace
GE
$374B
$119K 0.05%
3,019
-632
-17% -$20.5K
KGC icon
211
Kinross Gold
KGC
$27.4B
$116K 0.05%
15,059
-1,401
-9% -$12.1K
NLY icon
212
Annaly Capital Management
NLY
$17.1B
$100K 0.04%
3,323
-216
-6% -$6.25K
CTSO icon
213
Cytosorbents Corp
CTSO
$22.7M
$97K 0.04%
12,150
-1,350
-10% -$12.2K
BCRX icon
214
BioCryst Pharmaceuticals
BCRX
$2.28B
$89K 0.04%
24,800
+5,850
+31% +$25.1K
APTS
215
DELISTED
Preferred Apartment Communities, Inc.
APTS
$89K 0.04%
13,827
-3,898
-22% -$26.5K
AMRN
216
Amarin Corp
AMRN
$299M
$83K 0.04%
903
-177
-16% -$21.2K
PSLV icon
217
Sprott Physical Silver Trust
PSLV
$12B
$83K 0.04%
10,062
-920
-8% -$8.03K
GYRE icon
218
Gyre Therapeutics
GYRE
$641M
$79K 0.04%
2,375
-66
-3% -$2.58K
OXLC
219
Oxford Lane Capital
OXLC
$894M
$58K 0.03%
+2,565
New +$54.9K
AGRX
220
DELISTED
Agile Therapeutics
AGRX
$58K 0.03%
10
-1
-9% -$5.73K
DBRG icon
221
DigitalBridge
DBRG
$2.93B
$48K 0.02%
3,346
+432
+15% +$4.18K
VSTM icon
222
Verastem
VSTM
$510M
$37K 0.02%
2,438
HTGM
223
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$24K 0.01%
405
SNMP
224
DELISTED
Evolve Transition Infrastructure LP
SNMP
$11K ﹤0.01%
701
ADEA icon
225
Adeia
ADEA
$2.94B
-453,649
Closed -$1.82M

Similar funds

Kalos Management's Q3 2020 Portfolio in Review

As of Q3 2020, Kalos Management held 249 positions worth $224M, down 5.6% from $237M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Kalos Management withdrew a net $18.5M in Q3 2020, closing 16 positions and reducing 130 holdings. Its most notable exit was iShares US Consumer Staples ETF, an estimated $2.95M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Kalos Management opened a new position in iShares S&P Mid-Cap 400 Growth ETF worth $3.61M.

  • Kalos Management's largest Q3 2020 buy was iShares S&P Mid-Cap 400 Growth ETF: 142,880 shares worth $3.61M.
  • Kalos Management added most to Schwab US Large- Cap ETF in Q3 2020, an estimated $2.58M increase.
  • Kalos Management's biggest Q3 2020 reduction was Schwab US Broad Market ETF, cutting an estimated $4.34M.
  • Kalos Management fully exited iShares US Consumer Staples ETF in Q3 2020, selling an estimated $2.95M.
  • Kalos Management's ten largest holdings make up 19% of its $224M portfolio in Q3 2020.
  • Kalos Management opened 32 new positions and closed 16 in Q3 2020.
  • Kalos Management's portfolio value fell 5.6% quarter-over-quarter to $224M.

Based on Kalos Management's 13F filing for Q3 2020, filed 12 Nov 2020.